VX-710 blocker of the p-glycoprotein pump that ejects chemotherapeutics from cancer cells: Began a Phase I dose escalation trial in 45 patients receiving paclit

By WIR Staff | Nov 14, 1994 | 8:00 AM GMT

Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass.
Product:

Read the full 73 word article

How to gain access

Continue reading with a
two-week free trial.